Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Interest Coverage Ratio (2020 - 2023)

Historic Interest Coverage Ratio for Relay Therapeutics (RLAY) over the last 4 years, with Q1 2023 value amounting to 33725.67.

  • Relay Therapeutics' Interest Coverage Ratio fell 102918.96% to 33725.67 in Q1 2023 from the same period last year, while for Dec 2023 it was 124333.33, marking a year-over-year decrease of 77244.17%. This contributed to the annual value of 91174.5 for FY2021, which is 251451.0% down from last year.
  • Relay Therapeutics' Interest Coverage Ratio amounted to 33725.67 in Q1 2023, which was down 102918.96% from 2986.71 recorded in Q1 2022.
  • Relay Therapeutics' Interest Coverage Ratio's 5-year high stood at 4373.5 during Q4 2020, with a 5-year trough of 33725.67 in Q1 2023.
  • In the last 4 years, Relay Therapeutics' Interest Coverage Ratio had a median value of 7901.2 in 2020 and averaged 9563.49.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first surged by 6478.35% in 2022, then tumbled by 102918.96% in 2023.
  • Relay Therapeutics' Interest Coverage Ratio (Quarter) stood at 4373.5 in 2020, then tumbled by 293.92% to 8481.0 in 2021, then surged by 64.78% to 2986.71 in 2022, then tumbled by 1029.19% to 33725.67 in 2023.
  • Its last three reported values are 33725.67 in Q1 2023, 2986.71 for Q1 2022, and 8481.0 during Q1 2021.